Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 07:05 ET | Source: Research and Markets

Automated Cell Processing Systems Market Report 2026-2035: Industry Poised for 16% CAGR Growth Amid Biotechnology Breakthroughs

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of...
March 31, 2026 11:04 ET | Source: Research and Markets

Precision Medicine Software Market Outlook 2026-2030 & 2035 - Philips, Palantir Technologies, and Tempus Labs Lead the $2.82 Billion Industry

Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The precision medicine software market is...
March 27, 2026 10:44 ET | Source: Research and Markets

Oncology Precision Medicine Market Trends and Investment Opportunities 2026-2030 - Advancements in CAR-T and Gene Therapies Propel Precision Oncology Growth

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology precision medicine market is...
March 24, 2026 09:46 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 08:37 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 06:00 ET | Source: Yatiri Bio

Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML

Yatiri Bio is a precision medicine company focused on identifying and validating biomarkers that predict therapeutic response in oncology.
March 19, 2026 10:00 ET | Source: Diadia Health

Diadia Launches AI Platform to Finally Give Women Answers to "Unexplained" Health Problems

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- For women suffering from unexplained infertility, crushing fatigue, or resistant weight gain, hearing "your labs are normal" can feel like a dead end....
March 18, 2026 11:59 ET | Source: Mindera Health

Mindera Health™ and Mountaineer Biosciences Launch Subtilitas, a Precision Translational Medicine Platform for Dermatology and Immunology

Vista, CA, March 18, 2026 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, and Mountaineer Biosciences today announced the launch of Subtilitas, a...
March 17, 2026 17:01 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric...
March 17, 2026 07:45 ET | Source: SNS Insider pvt ltd

Predictive Biomarkers Market to Reach USD 156.85 Billion by 2035; Rising Adoption of Precision Medicine and Targeted Therapies Driving Market Growth – SNS Insider

Austin, United States, March 17, 2026 (GLOBE NEWSWIRE) -- Predictive Biomarkers Market Size & Growth Analysis: According to SNS Insider, The Predictive Biomarkers Market size is estimated at...